Combination chemotherapy in androgen-independent metastatic prostate cancer. A phase II study with docetaxel and ifosfamide
- Kellokumpu-Lehtinen, P. (Speaker)
Activity: Talk or presentation › Conference presentation
Activity: Talk or presentation › Conference presentation